ChordNews
← All news

Amgen projects 2026 revenue of $38.9B-$39.7B while raising non-GAAP EPS to $22.90-$23.70

By ChordNews · First written (updated )

Comments 0

Summary

Amgen has projected 2026 revenue of $38.9B-$39.7B and raised its non-GAAP EPS outlook to $22.90-$23.70, according to a Seeking Alpha headline published November 4, 2026. The reporting available is a headline only, so no further figures, drivers or context are confirmed.

This continues an earlier story: Novocure outlines 2026 net revenue of $736M-$743M and updates adjusted EBITDA to $24M-$34M

Later: Halozyme projects 2026 revenue of $1.86B-$1.925B and raises non-GAAP EPS outlook to $8.75-$9.05

Timeline

  1. Seeking Alpha

    Source ↗

    Seeking Alpha reports that Amgen projects 2026 revenue of $38.9B-$39.7B while raising non-GAAP EPS to $22.90-$23.70.

Comments

No comments yet.

    to like and comment.

    © 2026 ChordNews